NCT02965664View on ClinicalTrials.gov

Safety, Tolerability and Efficacy of PresbiDrops (CSF-1) in Presbyopic Subjects

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

April 30, 2017

Study Completion Date

April 30, 2017

Conditions
Presbyopia
Interventions
DRUG

PresbiDrops (CSF-1)

PresbiDrops (CSF-1) is a topical ophthalmic drug.

DRUG

Placebo

Placebo drops contain the same ingredients as PresbiDrops except for the active ingredients

Trial Locations (2)

22100

Ophthalmology Department, Western Galilee Medical Center, Nahariya

76100

The Department of Ophthalmology, Kaplan Medical Center, Rehovot

Sponsors
All Listed Sponsors
lead

Orasis Pharmaceuticals Ltd.

INDUSTRY